徐华强，男，美国国籍，毕业于，在1985与1988年分别获得学士与硕士学位，随后于1994年获得美国德州西南医学中心博士学位，而后两年在美国从事博士后研究。1996年到2002年，先后在葛兰素威康研究所和美国任研究员。2002年任美国Van Andel研究所结构科学实验室主任，2007年提升为杰出教授和药物研发中心主任。2010年7月以国家“千人计划”特聘教授身份回到中国科学院上海药物研究所并创建药物靶结构与功能中心。
现任受体结构与功能重点实验室主任，药物靶标结构与功能中心主任、教授，中国科学院上海药物研究所VARI/SIMM研究中心主任、杰出PI。
1980-1985 核子物理工程专业，学士学位1985-1988 清华大学生物物理专业，硕士学位1989-1990 美国植物遗传系1991-1994 美国西南医学中心，生物化学与分子生物学专业，博士1994-1996 美国(MIT)生物系, 哈佛休斯医学研究所，研究助理1996-1999 美国格兰素威康研究所结构化学系，一级研究院1999-2001 美国格兰素威康研究所结构化学系，二级研究员2001-2002 美国GSK研究所结构科学部，高级研究人员2002-2007.3 美国Van Andel研究所结构科学部实验室负责人，资深PI/教授2007.3-2009.12 美国Van Andel研究所结构科学部实验室负责人，杰出PI/教授2010.1-至今 美国Van Andel研究所结构科学与药物发现中心主任，实验室负责人，杰出PI/教授2010.7-至今 2009年入选国家，现担任研究员主要研究领域集中在核激素受体、肝脏生长因子(HGF)受体、G蛋白偶联受体(GPCR)、和受体等结构与功能领域的研究，开展基于晶体结构的肿瘤与的药物研发。
千人计划，研究员专利:1. Activators of PPAR delta. US Patent Number 6,710,063. Issued 03/23/2004.2. Activator of PPAR delta. US Patent Number 6,723,740. Issued 04/20/2004.3. Activator of PPAR delta. US Patent Application Serial Number 10/383,011. Filed 03/06/2003.4. Crystallized PPARα Ligand Binding Domain Polypeptide and Screening Methods Employing Same. US Patent Application Serial Number 10/467,048. Filed 08/01/2003.5. Crystallized Glucocorticoid Receptor Ligand Binding Domain Polypeptide and Screening Methods Employing Same. US Patent Application Serial Number 10/484,061. Filed 01/16/2004.6. Ligands for Orphan Nuclear Hormone Receptor Steroidogenic Factor-1 (SF-1). US Patent Application Serial Number 11/348,207. Filed 02/06/2006.7. Ligands for Mineralocorticoid Receptor (MR) and Methods for Screening for or Designing MR Ligands. PCT Patent Application Serial Number PCT/US2006/044620. Filed 11/15/2006.文章:2009年发表ABA受体研究新成果文章“脱落酸受体晶体结构与分子机制” 发表在《自然》封面文章，被《科学》杂志评为2009年十大突破之一。已在《》、《》、《》、《》等杂志发表论文110余篇，并获得专利十余项。
1.973， 离子通道和膜转运蛋白的结构与功能研究，2013.1-2017.82.重大专项， 基于GPCR结构与功能的药物发现关键技术发展与平台建设， 2012.1-2015.12 　　3.基金委项目， 与神经系统疾病相关的离子通道的结构与功能研究， 2012.1-2015.12 　　4.基金委项目， 独脚金内酯的信号传导机制研究， 2013.1-2015.12 　　5.中科院， 国家千人计划启动资助/中科院创新工程试点， 2010.1-2014.12
1993年获美国德州大学西南医学中心the Twenty-Fifth Sigma Xi研究生研究奖1999年获格兰素威康杰出研究奖2001年9月获GSK杰出研究奖2016年3月获国际蛋白质学会Hans Neurath奖
2016年12月获杰出成就奖
2009-2011年发表论文2009-2011年发表论文1.He Y, Xu Y, Zhang C, Gao X, Dykema, KJ, Martin KR, Ke J, Hudson EA, Khoo SK, Resau JH, Alberts AS, MacKeigan JP, Furge KA, and Xu HE (2011). Identification of a lysosomal pathway that potently modulates glucocorticoid signaling and inflammation response. Science Signaling (2011) (in press).2.Serkan K, Beddow SA, Samuel VT, Miller P, Previs, SF, Suino-Powell K, Schulman G, Xu HE, Kliewer SA, and Mangelsdorf D (2011) FGF19 is a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis.  (in press)3.Huh JR, Leung MWL, Huang P, Ryan DA, Krout MR, Malapaka R, Chow J, Manel N, Ciofani M, Kim SV, Cuesta A, Santori FR, Lafaille JJ, Xu HE, Gin DY, Rastinejad F, and Littman DR. (2011). Digoxin and its derivatives suppress Th17 cell differentiation by antagonizing RORγt activity. (in press).4.Zhou XE, Suino-Powell KM, Xu Y, Chan CW, Kruse SW, Reynolds R, Engel JD, Xu HE. (2010) The orphan nuclear receptor TR4 is a vitamin A-activated nuclear receptor. J Biol Chem. 2010 Nov 9. [Epub ahead of print] (featured as Paper of the week)5.Pal K, Swaminathan K, Xu HE, Pioszak AA.(2010). 2.Structural basis for hormone recognition by the human CRFR2alpha G protein-coupled receptor. J Biol Chem. 2010 Oct 21. [Epub ahead of print]6.Melcher K, Zhou XE, and Xu HE (2010) Thirsty plants and beyond: structural mechanisms of abscisic acid perception and signaling. Current Opinion in Structural Biology (In press).7.Tolbert WD, Daugherty-Holtrop J, Gherardi E, Vande Woude G, and Xu HE (2010) Structural basis for agonism and antagonism of hepatocyte growth factor. , 107:13264-9.8.Melcher K, Xu Y, Ng LM, Zhou XE, Soon FF, Suino-Powell KM, Chinnusamy V, Kovach A, , Cutler SR, Li J, , Yong ELZhu JK, Xu HE (2010) Identification and Mechanism of ABA Receptor Antagonism. Nature Structural& Molecular Biology 17(9):1102-8.9.Powell E, Huang SX, Xu Y, Rajski SR, Wang Y, Peters N, Guo S, Xu HE, Hoffmann FM, Shen B, Xu W. (2010) Identification and characterization of a novel estrogenic ligand actinopolymorphol A. Biochem Pharmacol. 80(8):1221-9. PMID: 2059977810.Pal K, Kumar S, Sharma S, Garg SK, Alam MS, Xu HE, Agrawal P, Swaminathan K. (2010). Crystal Structure of Full-length Mycobacterium tuberculosis H37Rv Glycogen Branching Enzyme: INSIGHTS OF N-TERMINAL {BETA}-SANDWICH IN SUBSTRATE SPECIFICITY AND ENZYMATIC ACTIVITY. JBC 285(27):20897-903. EPUB 2010 MAY 5.11.Pioszak AA, Harikumar KG, Parker NR, Miller LJ, Xu HE. (2010) Dimeric arrangement of the parathyroid hormone receptor and a structural mechanism for ligand-induced dissociation. JBC 285(16):12435-44. Epub 2010 Feb 19. PMID: 2017285512.Zhou XE, Suino-Powell KM, Li J, He Y, Mackeigan JP, Melcher K, Yong EL, and Xu HE (2010) Identification of SRC3/AIB1 as A Preferred Coactivator for Hormone-Activated Androgen Receptor. JBC, January 19 Epub. (Featured as the cover article and the paper of the week by JBC). Mar 19;285(12):9161-71. PMID: 2008601013.Schopfer FJ, Cole MP, Groeger A, Chen CS, Woodcock SR, Khoo N, Golin-Bisello F, Motanya UN, Rudolph TK, Rudolph V, Bonacci G, Baker PRS, Batthyany CI, Xu HE, Y. Chen YE, Hallis TM, and Freeman BA (2010) Covalent Peroxisome Proliferator-Activated Receptor γ Binding by Nitro-Fatty Acids: Endogenous Ligands Act as Selective Modulators. JBC, 2010 Apr 16;285(16):12321-33.14.Epub 2010 Jan 22.Zhou XE, Suino-Powell K, Ludidi PL, McDonnell DP, Xu HE (2010) Expression, purification and primary crystallographic study of human androgen receptor in complex with DNA and coactivator motifs. Protein Expr Purif. 71(1):21-7.15.Melcher K, Ng LM, Zhou XE, Soon FF, Xu Y, Suino-Powell KM, Park SY, Weiner JJ, Fujii H, Chinnusamy V, Kovach A, Li J, Wang Y, Li J, Peterson FC, Jensen DR, Yong EL, Volkman BF, Cutler SR, Zhu JK, Xu HE (2009) A gate-latch-lock mechanism for hormone signaling by abscisic acid receptors. Nature 2009 Dec 3;462(7273):602-8 (Cover Article, featured as one of top 10 breakthroughs of 2009 by Science). PMID: 1989842016.Pioszak AA, and Xu HE. (2009) Molecular recognition of parathyroid hormone-related peptide (PTHrP) by the extracellular domain of its G protein-coupled receptor PTH1R. JBC, 2009 Aug 12. [Epub ahead of print] PMID: 1967496717.Knudsen, BS., Zhao P, Resau J, Cottingham S, Gherardi E, Xu HE, Berghuis B, Daugherty J, Grabinski T, Toro J, Giambernardi T, Skinner RS, Gross M, Hudson E, Kort E, Lengyel E, Ventura A, West RA, Xie Q, Hay R, Vande Woude G, and Cao B. 2009. A novel multipurpose monoclonal antibody for evaluating human c-Met expression in preclinical and clinical settings. Applied Immunohistochemistry and Molecular Morphology 17(1): 56–67.18.Wang Z, Zhou XE, et al, Xu HE, Mangelsdorf DJ. (2009) Control of Nematode Parasitism by Conserved Nuclear Receptor Signaling. PNAS 106, 9138-43.19.Miao J, Kanamaluru D, Min G, Yau PM, Ellis E, Storm S, Suino-Powell K, Xu HE, Kemper JK (2009). Stability of Small Heterodimer Partner (SHP) is increased by bile acids and fibroblast growth factor 19. Genes and Development, 23:986-96.20.Chakravarthy MV, Lodhi IJ, Yin L, Malapaka RV, Xu HE, Turk J, and Semenkovich CF (2009) Identification of the Physiologically Relevant Endogenous Ligand for PPARα in Liver. Cell, 138(3):476-88. PMID: 19646743清华大学麻省理工学院葛兰素史克 中国科学院中国科学院上海药物研究所 清华大学杜克大学德州大学麻省理工学院千人计划中国科学院上海药物研究所离子通道植物激素糖尿病    药明康德生命化学研究奖 ScienceNaturePNAS